Erythrocyte-derived nanoparticles for light activated combination of chemo-photothermal therapy of tumors
Ended Project Grant Awarded Last action
- Award ID
- R43CA228692
- Recipient
-
Radoptics LLC UEI STK3MLEK1CG5
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $264,517
Award facts
- Assistance listing
- 93.396 Cancer Biology Research
- Completion date
- Originally
- Place of performance
- California, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Original award | $264,517 |
Quick answers
Who received award R43CA228692?
R43CA228692 was awarded to Radoptics LLC by National Cancer Institute (National Institutes of Health) on August 1, 2018.
How much is award R43CA228692 worth?
$264,517 has been obligated on R43CA228692.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award